STOCK TITAN

Carter Bankshares Inc SEC Filings

CARE NASDAQ

Welcome to our dedicated page for Carter Bankshares SEC filings (Ticker: CARE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Carter Bankshares, Inc. (NASDAQ: CARE), the Virginia‑incorporated bank holding company for Carter Bank. Through these filings, investors can review the company’s formal disclosures on financial condition, capital, asset quality, risk factors and corporate actions.

Carter Bankshares, Inc. uses Form 8‑K to report material events, including quarterly and annual earnings releases, investor presentations, regulatory developments and other significant updates. For example, 8‑K filings reference press releases announcing financial results for periods such as the three and nine months ended September 30, 2025, as well as the year ended December 31, 2024. Other 8‑K filings furnish investor presentations dated as of quarter‑end and describe regulatory milestones, such as Carter Bank’s approval to become a state member bank of the Federal Reserve System.

Annual reports on Form 10‑K and quarterly reports on Form 10‑Q (accessible via the SEC’s EDGAR system) contain detailed information on loan and deposit portfolios, net interest income, noninterest income and expense, nonperforming loans, allowance for credit losses and the large credit relationship in the "Other" segment of the loan portfolio. These reports also include risk factor discussions and management’s analysis of the impact of nonaccrual loans related to the Justice Entities.

Investors can also review filings related to capital and governance, such as disclosures about stock repurchase programs, financial holding company status and regulatory oversight. Forms reporting executive or director share transactions (such as Form 4, when available) help track insider trading activity in CARE common stock.

Stock Titan’s platform enhances these filings with AI‑powered summaries that highlight key points from lengthy documents, explain technical terms and surface items such as changes in credit quality, capital ratios, branch transactions and regulatory developments. Real‑time updates from EDGAR ensure that new 10‑K, 10‑Q, 8‑K and other filings for Carter Bankshares, Inc. are available promptly, while AI insights help readers focus on the most important disclosures without manually parsing every page.

Rhea-AI Summary

Carter Bankshares (CARE) director James W. Haskins reported an open-market sale of 2,000 common shares on 07/28/2025 at $17.84 each.

  • Gross proceeds: ≈$35,680.
  • Post-sale holdings: 61,900 shares held directly and 1,751 shares held indirectly through his spouse.
  • No derivative securities were reported.

The filing signals a modest reduction in insider ownership but the director retains a sizeable stake, maintaining alignment with shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.27%
Tags
current report

FAQ

How many Carter Bankshares (CARE) SEC filings are available on StockTitan?

StockTitan tracks 42 SEC filings for Carter Bankshares (CARE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Carter Bankshares (CARE)?

The most recent SEC filing for Carter Bankshares (CARE) was filed on July 28, 2025.